Johnson Investment Counsel Inc Meridian Bioscience Inc Transaction History

Johnson Investment Counsel Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$19.97 - $26.94 $9,985 - $13,470	-500 Reduced 2.61%	18,622 $483,000
Q3 2021 Nov 12, 2021	SELL	$17.35 - $22.5 $17,350 - $22,500	-1,000 Reduced 4.97%	19,122 $368,000
Q1 2021 May 14, 2021	SELL	$19.76 - $29.89 $79,040 - $119,560	-4,000 Reduced 16.58%	20,122 $528,000
Q4 2020 Feb 12, 2021	SELL	$15.73 - $21.66 $31,066 - $42,778	-1,975 Reduced 7.57%	24,122 $451,000
Q3 2020 Nov 16, 2020	BUY	$13.54 - $26.41 $104,190 - $203,224	7,695 Added 41.82%	26,097 $443,000
Q2 2020 Aug 13, 2020	BUY	$7.84 - $23.29 $144,271 - $428,582	18,402 New	18,402 $429,000
Q1 2020 May 20, 2020	SELL	$5.57 - $11.5 $117,905 - $243,432	-21,168 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$7.9 - $10.14 $9,882 - $12,685	1,251 Added 6.28%	21,168 $207,000
Q2 2019 Aug 14, 2019	BUY	$10.88 - $17.6 $27,722 - $44,844	2,548 Added 14.67%	19,917 $236,000
Q4 2018 Feb 13, 2019	BUY	$14.52 - $19.72 $35,603 - $48,353	2,452 Added 16.44%	17,369 $301,000
Q1 2018 May 15, 2018	SELL	$13.8 - $16.2 $18,947 - $22,242	-1,373 Reduced 8.43%	14,917 $211,000
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $219,100 - $233,761	16,290	16,290 $232,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Johnson Investment Counsel Inc with notifications on news.